GlassScriptPhysician profile
Ming Charles Li
NPI 1770843054
$25,754.01
in general payments reported to CMS, 2019-2025
96 companies · $4,645 in 2025
The $4,645 reported for 2025 was more than what 81% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,005 · 2020: $2,781 · 2021: $2,935 · 2022: $3,493 · 2023: $4,550 · 2024: $4,345 · 2025: $4,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Long Term Medical Supply Or Device Loan: $2,250 · Consulting Fee: $818 · Education: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,120.12 |
| Long Term Medical Supply Or Device Loan | $2,249.91 |
| Consulting Fee | $817.50 |
| Education | $351.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $5,679.42 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,666.09 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Astrazeneca Pharmaceuticals LP | $1,326.56 | 2019-2025 | Imfinzi, Calquence, Lynparza |
| Incyte Corporation | $1,075.33 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Janssen Biotech, INC. | $898.96 | 2019-2025 | Erleada, Rybrevant, Tecvayli |
| Janssen Scientific Affairs, LLC | $817.50 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $757.08 | 2019-2025 | Opdivo, Opdualag |
| Pharmacyclics LLC, An Abbvie Company | $682.16 | 2019-2023 | Imbruvica |
| Celgene Corporation | $617.47 | 2020-2025 | Reblozyl, Opdualag, Pomalyst |
| Daiichi Sankyo INC. | $529.59 | 2019-2025 | Enhertu, Injectafer |
| Pfizer INC. | $500.67 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $494.09 | 2019-2025 | Fruzaqla, Iclusig, Alunbrig |
| Genentech USA, INC. | $488.81 | 2019-2025 | Polivy, Phesgo, Venclexta |
| Abbvie INC. | $479.57 | 2019-2025 | |
| Astellas Pharma US INC | $469.09 | 2019-2025 | Padcev, Vyloy, Xospata |
Show all 96 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $396.73 | 2019-2025 | Trodelvy |
| Glaxosmithkline, LLC. | $388.51 | 2020-2025 | Ojjaara, Jemperli, Shingrix |
| Rigel Pharmaceuticals, INC. | $371.64 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Eisai INC. | $358.35 | 2019-2025 | |
| Amgen INC. | $353.56 | 2019-2025 | Kyprolis, Blincyto, Lumakras |
| Athenex Pharmaceutical Division, LLC | $350.00 | 2020 | |
| Puma Biotechnology, INC. | $334.63 | 2019-2025 | |
| Lilly USA, LLC | $325.38 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Seagen INC. | $316.56 | 2019-2023 | Adcetris, Padcev |
| Karyopharm Therapeutics INC. | $310.97 | 2020-2025 | Xpovio |
| Bayer Healthcare Pharmaceuticals INC. | $304.21 | 2019-2025 | |
| Beigene USA, INC. | $276.19 | 2020-2025 | Brukinsa, Tevimbra |
| Genzyme Corporation | $272.28 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $231.40 | 2019-2024 | Ultomiris |
| Pharmaessentia USA Corporation | $215.96 | 2022-2025 | Besremi |
| Blueprint Medicines Corporation | $215.01 | 2021-2025 | Ayvakit |
| Coherus Oncology, INC. | $211.69 | 2021-2025 | Loqtorzi, Udenyca |
| Exelixis INC. | $203.55 | 2019-2024 | Cabometyx |
| Janssen Pharmaceuticals, INC | $200.51 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.81 | 2020-2025 | Gilotrif |
| Aveo Pharmaceuticals, INC. | $161.07 | 2022-2025 | Fotivda |
| Array Biopharma INC | $150.97 | 2022-2025 | Mektovi, Braftovi, Lorbrena |
| Stemline Therapeutics INC. | $141.06 | 2019-2024 | Orserdu, Elzonris |
| Tersera Therapeutics LLC | $133.84 | 2019-2024 | Quzyttir |
| Emd Serono, INC. | $115.94 | 2019-2025 | Bavencio |
| Deciphera Pharmaceuticals INC. | $115.57 | 2022-2024 | Qinlock |
| Sobi, INC | $115.45 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $113.35 | 2023-2025 | Orgovyx |
| Beone Medicines USA, INC. | $111.65 | 2025 | Brukinsa, Tevimbra |
| Amag Pharmaceuticals, INC. | $101.44 | 2019-2021 | |
| Adc Therapeutics America, INC. | $99.17 | 2023-2025 | |
| Morphosys, US INC. | $94.25 | 2021-2023 | Monjuvi |
| Regeneron Healthcare Solutions, INC. | $93.81 | 2022-2025 | Libtayo |
| Kite Pharma, INC. | $89.87 | 2020-2024 | Yescarta |
| Tempus Ai, INC | $88.06 | 2024 | |
| Myovant Sciences INC. | $87.54 | 2021-2022 | |
| Taiho Oncology, INC. | $82.29 | 2023-2025 | |
| Genmab U.S., INC. | $79.12 | 2023-2025 | Epkinly |
| Recordati_rare_diseases_inc. | $70.64 | 2024-2025 | Sylvant, Enjaymo |
| Mylan Institutional INC. | $70.36 | 2019-2021 | |
| Servier Pharmaceuticals LLC | $62.55 | 2022-2024 | |
| Eusa Pharma (US) LLC | $61.79 | 2020-2022 | |
| Ipsen Biopharmaceuticals, INC | $55.51 | 2020-2024 | Somatuline Depot, Onivyde |
| Dendreon Pharmaceuticals LLC | $52.01 | 2019 | |
| Alnylam Pharmaceuticals INC. | $48.67 | 2023-2025 | Givlaari |
| Medexus Pharma, INC. | $47.24 | 2025 | Grafapex |
| Iovance Biotherapeutics, INC. | $46.63 | 2025 | Amtagvi |
| Springworks Therapeutics, INC. | $45.95 | 2024-2025 | Ogsiveo |
| Aurobindo Pharma USA, INC. | $43.88 | 2020 | |
| Mirati Therapeutics, INC. | $43.41 | 2023-2024 | Krazati |
| Cti Biopharma Corp. | $43.19 | 2023 | Vonjo |
| Agios Pharmaceuticals, INC. | $40.61 | 2019-2025 | Pyrukynd |
| Sirtex Medical INC | $39.62 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $39.25 | 2019-2020 | |
| Ge Healthcare | $38.16 | 2025 | |
| Epizyme, INC. | $36.95 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $35.42 | 2023-2024 | Zepzelca |
| Kyowa Kirin, INC. | $35.39 | 2019-2023 | Poteligeo |
| Sanofi-Aventis U.S. LLC | $31.52 | 2019-2020 | |
| Dova Pharmaceuticals | $30.75 | 2019-2020 | |
| Chiesi USA, INC. | $28.63 | 2024-2025 | Ferriprox |
| Immunogen, INC. | $27.93 | 2023 | Elahere |
| Progenics Pharmaceuticals, INC. | $25.96 | 2022 | |
| Adaptive Biotechnologies Corporation | $24.80 | 2023 | Clonoseq |
| Blue Earth Diagnostics | $24.73 | 2019 | |
| Verastem, INC. | $24.41 | 2019 | |
| Tg Therapeutics, INC. | $24.02 | 2021 | |
| Geron Corporation | $22.50 | 2024 | Rytelo |
| Sun Pharmaceutical Industries INC. | $22.22 | 2020 | |
| Azurity Pharmaceuticals, INC. | $21.79 | 2025 | Danziten |
| Acrotech Biopharma INC. | $21.56 | 2022 | |
| Immunocore Limited | $21.01 | 2024 | Kimmtrak |
| Fennec Pharmaceuticals, INC. | $20.23 | 2025 | Fyarro |
| Pharmacosmos Therapeutics INC. | $19.92 | 2025 | Monoferric |
| Portola Pharmaceuticals, LLC | $18.85 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $18.54 | 2019 | |
| Clovis Oncology, INC. | $18.38 | 2020 | |
| Foundation Medicine, INC. | $17.45 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $16.39 | 2019 | |
| Syndax Pharmaceuticals, INC. | $16.18 | 2025 | |
| Helsinn Therapeutics (U.S.), INC. | $14.23 | 2019 |
Drugs and devices associated with these payments
Kisqali $2,465Keytruda $964Reblozyl $346Enhertu $329Jakafi $254Imfinzi $246Xpovio $221Opdivo $217Calquence $213Pluvicto $200Brukinsa $196Erleada $177Lynparza $172Orgovyx $163Lenvima $161Ayvakit $161Monjuvi $161Rezlidhia $160Tavalisse $160Epkinly $157Besremi $150Imbruvica $145Mektovi $129Elahere $128Opdualag $124Jaypirca $124Padcev $117Fotivda $116Nerlynx $114Braftovi $114Rybrevant $113Piqray $111Fabhalta $103Adcetris $101Venclexta $99.47Orserdu $98.15Gilotrif $97.11Verzenio $96.53Tukysa $96.45Trodelvy $96.41Cabometyx $95.76Udenyca $93.44Welireg $91.77Qinlock $90.81Tevimbra $86.14Fruzaqla $84.88Polivy $83.00Scemblix $82.98Lonsurf $82.29Inqovi $82.29Loqtorzi $81.95Pemazyre $81.66Xtandi $81.57Mekinist $73.80Nubeqa $72.33Iclusig $72.28Ojjaara $66.84Lorbrena $66.47Xalkori $66.47Phesgo $65.93Vyloy $65.79Libtayo $64.93Gavreto $64.48Alunbrig $63.66Doptelet $60.59Tecvayli $60.29Vonjo $59.86Ibrance $58.21Quzyttir $57.32Sarclisa $55.95Zynlonta $54.48Talzenna $49.99Givlaari $48.67Elrexfio $47.51Grafapex $47.24Sylvant $47.22Perjeta $47.20Kadcyla $47.20Bosulif $47.14Retevmo $47.12Amtagvi $46.63Ogsiveo $45.95Itovebi $45.64Krazati $43.41Yescarta $42.51Ultomiris $38.71Kyprolis $38.33Tibsovo $38.09Idhifa $38.09Onivyde $36.92Somatuline Depot $36.92Zepzelca $35.42Darzalex $34.05Xospata $33.34Tagrisso $32.69Cuvitru $30.07Lunsumio $29.51Columvi $29.51Ferriprox $28.63Injectafer $28.03
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ming Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.